Consistent with previous studies [31], mice inoculated with CT26 cells and treated with CD8α mAb exhibited CD8+ T cell suppression and a significant increase in tumor burden compared to those treated with IgG2b (Supplementary Fig. S9B–D). Here, CD8A is linked to neoplasm.